8220; legal verdicts on drug administration.
There's enough evidence to make a personal decision about whether to keep taking these drugs, so I'll just keep on doing that. And I'll ask Bernard and Diane if you want any last, for instance, paroxetine sertraline.
Inflamed joints of patients with septicaemia. None of the case histories are very detailed, and they did not really add anything new to Billroth's observations from 1874. Billroth still contested a causal relationship of streptococci with clinical disease, and he maintained the concept of Coccobacteria septica. It was the reading of this article that prompted Salomonsen to publish his nearly five-year-old clinical study 1 ; . The results from his thesis had convinced him that Billroth's concept of Coccobacteria septica was wrong, and it therefore made good sense to focus on streptococci as a phenotypic entity and try to prove a causal relationship with pyaemia in humans. Compared with the standards of his time Salomonsen's clinical studies are of high quality, and we may regret that he did not publish them earlier and in an international journal. This would have made him one of the very first to link streptococci with clinical disease. Today Billroth is given the credit for this 8 ; , which is history's irony, since he neither believed in streptococci as a stable phenotype, nor in their causative role in disease 3, 7 ; . One important observation in the above-referred case history did not fit with Salomon's hypothesis that streptococci were the cause of the patient's disease. On 29 December, when he punctured the patient's shoulder joint for the second time, he not only demonstrated streptococci, but also huge amounts of Bacterium termo, a motile rod. The day before he had punctured the same joint and only found streptococci, and after aspiration of pus he had instilled a sulphurous acid solution for disinfecting the joint cavity. His own explanation for this unexpected finding was that the new organism had been introduced from outside in conjunction with the aspiration and instillation procedures. This seems probable, since they were performed without antiseptic precautions. As such it may be regarded as one of earliest records of a bacterially-verified hospital-acquired infection.
Sleepwalking and sleep-disordered breathing Chouinard, 1984; Schenck et al., 1989; Schenck and Mahowald, 1996 ; , triazolam Berlin and Qayyum, 1986 ; , flurazepam Mendelson, 2000 ; ], tricyclic antidepressants [e.g. imipramine in adults with sleep terrors and sleepwalking Marshall, 1975; Cooper, 1987; Garland and Smithe, 1991 ; ] and serotonin-selective reuptake inhibitors SSRIs ; [paroxetine Lillywhite, 1994 ; ]. But the pharmacological treatment of sleepwalking remains largely anecdotal Remulla and Guilleminault, 2004 ; . For the past 25 years, all adult sleepwalkers referred to the sleep clinic due to the chronicity of their behaviour, disturbance to their environment and trauma risks to themselves or others have been submitted to the same diagnostic protocol evaluation, with sleep-deprived clinical EEG awake and asleep, urine drug screen, and nocturnal polysomnography PSG ; . Rarely, the chronic abnormal behaviour was related to a seizure disorder. In over 97% of the cases, the chronic behaviour was classified as sleepwalking parasomnia ; . Over the years, we began to appreciate the frequency with which other sleep disorders were also shown in the PSGs, and we began treating the associated sleep disorder as the first therapeutic approach. As part of an overall evaluation of procedures and protocols, we performed a 4-year retrospective analysis of clinical and polysomnographic findings and response to treatment of adult individuals who had at least two follow-ups with one at least a year after initial evaluation. One hundred and one subjects mean age 25.2 6 5 years; 33 women ; were identified in the database. Initiation of treatment and scheduled follow-up were determined based on the.
Paroxetine hcl drug antidepressants
These drugs work by targeting the body's neurotransmitters.
The Food and Drug Administration and the U.S. Public Health Service have rejected smoking crude marijuana as a medicine. 46 It is important to note that the Food and Drug Administration FDA ; has never approved medications that are smoked. ; This is because not only is it difficult if not impossible to administer safe and regulated dosages of medicine in a smoked form, the harmful chemicals and carcinogens that are by-products of smoking create an entirely new set of health problems. 47 and prandin.
The [3H]paroxetine binding Investigations concerning the presynaptic serotonin transporter have been performed using tritated imipramine or paroxetine. It has been suggested that [3H]paroxetine may be a more selective ligand for labeling the serotonin transporter Mellerup and Plenge, 1986 ; . The binding is described by two parameters Bmax the density of binding site ; and the dissociation constant Kd. Results from different studies of the density of binding sites for [3H]paroxetine in platelets in depression have not been as consistent as the 5-HT uptake results showing reduced Nemeroff et al., 1994 ; , unchanged Lawrence et al., 1994 ; as well as increased density Neuger et al., 1999 ; , whereas the dissociation constant Kd is normal. The [3H]LSD binding Investigations of postsynaptic 5-HT2A receptors have most commonly been performed using tritated LSD. Similarly to the [3H]paroxetine binding, this binding is described by the two parameters Bmax for the 5-HT2A receptor density and the dissociation constant Kd. Several studies have reported elevated 5-HT2A receptor density in blood platelets and in postmortem brain tissue of depressed patients and suicides Arora and Meltzer, 1989; Pandey et al., 1990; Yates et al., 1990 ; , whereas the dissociation constant Kd is normal. It has been suggested that upregulation of 5-HT2A receptors may be associated with aggression and suicidal ideation Hrdina et al., 1993; Pandey et al., 1995.
Home : order now : order status : medications list : shipping medications to your state : internet prescription : faq : bookmark us : contact us weight loss adipex bontril-sr didrex diethylpropion ionamin meridia phendimetrazine phenterlean hg phentermine alternative ; phentermine phenterprin tenuate xenical women's health diflucan estradiol evista fosamax levbid sl motrin naprosyn nordette 28 ovantra vaniqa men's health levitra viagra sexual health acyclovir aldara condylox denavir famvir valtrex zovirax skin care aphthasol atarax cleocin-t diprolene af dovonex elidel gris-peg kenalog lamisil nizoral penlac protopic renova retin-a synalar tretinoin headache butalbital depakote esgic fioricet imitrex imitrex oral pain relief bextra celebrex mobic naproxen tramadol ultracet ultram stop smoking zyban stomac aids aciphex bentyl nexium prevacid prilosec protonix ranitidine hcl anti depressants amitriptyline bupropion celexa fluoxetine lexapro paroxetine paxil prozac remeron wellbutrin sr zoloft anti anxiety alprazolam ativan buspar buspirone clonazepam effexor lorazepam valium xanax muscle relaxers carisoprodol cyclobenzaprine flexeril skelaxin soma zanaflex birth control alesse mircette ortho tri-cyclen ortho-evra seasonale triphasil yasmin anti allergy allegra claritin-d flonase nasacort nasonex patanol zyrtec hair loss propecia antibiotics cipro amoxicillin minocycline tetracycline trimox zithromax lower cholesterol lipitor blood pressure furosemide anti parasitics elimite eurax vermox joint & bone health actonel allopurinol colchicine zyloprim sleep aids ambien sonata motion sickness antivert meclizine promethazine overactive bladder detrol la flu medications tamiflu famvir they advise patients on the internet ukicrs ; , the first pharmaceutical society pages on the expiration date printed on the chain of events that occurred in 2% or more information and repaglinide.
Medical treatments for endometriosis oral contraceptives numerous brands ; birth control pills oral contraceptives or ocps ; have been used to treat endometriosis for more than 40 years.
The "ask a question" feature of the web site maintained by the Hospice Foundation of America is described. Sample questions are presented. The initial and current perspectives on this feature are provided by the hospice medical consultant who replies to questions sent to the web site. KEYWORDS. Hospice, palliative care, end-of-life, web site, questions, communications and pravastatin.
Number % ; of Patients with Emergent Adverse Experiences During the Treatment Phase by Intensity By Body System. Intention-To Treat Population Age Group : Adolescents Male Specific Adverse Experiences Intensity : Mild Paroetine N 27 ; Treatment Group Placebo N 26.
Paroxetine treatment of generalized anxiety disorder
This condensed Formulary is designed to serve as a reference guide and to assist in the selection of evidence-based, cost-effective pharmaceutical products. The Formulary is not intended to be a substitute for sound clinical knowledge and judgment. In all cases, the prescribing clinician is expected to select appropriate drug therapy for the individual consumer and provide the highest quality healthcare. Cenpatico Behavioral Health of Arizona Pharmacy and Therapeutics Committee will regularly review the Formulary to ensure it meets the needs of both consumers and providers. Consistent with the ADHS DBHS Medication List instructions, all formulary medications that are available in generic form are to be supplied in generic form. Any individual exception must be clinically appropriate and documented in the consumer's clinical record. Thank you in advance for your cooperation. Generic Name Diphenhydramine Disulfiram Divalproex ER Divalproex Sodium Docusate Sodium Escitalopram Fluoxetine Fluphenazine Flurazepam Fluvoxamine Guanfacine Haloperidol Hydroxyzine Imipramine Isocarboxazid Lamotrigene Levothyroxine Liothyronine Lithium Carbonate Lithium Carbonate SR Lithium Citrate Lorazepam Loxapine Meprobamate Methadone Methylphenidate Methylphenidate CR Methylphenidate ER Methylphenidate SR Mirtazapine Mixed Amphetamine Salts Mixed Amphatamines XR Molindone Multivitamin w Minerals Nadolol Naltrexone Nortriptyline Olanzapine Oxazepam Paroxeetine Paeoxetine CR Pentobarbital Perphenazine Phenelzine Phenobarbital Pimozide Prochlorperazine Promazine Propranolol Protriptyline Psyllium Pyridoxine Quetiapine Risperidone Sertraline Sulpiride Temazepam Thiamine Thioridazine Thiothixene Tranylcypromine Trazodone Brand Name Benadryl Antabuse Depakote ER Depakote Colace * Lexapro Prozac Prolixin Dalmane Luvox Tenex Haldol Atarax * Tofranil Marplan Lamictal Synthroid Cytomel Lithobid Eskalith CR Carbolith * Ativan Loxitane Equagesic Methadose * Ritalin Concerta Metadate CD * Ritalin LA * Remeron Adderall Adderall XR Moban Theragran-M * Corgard Revia Pamelor * Zyprexa Serax Paxil Paxil CR Nembutal Trilafon Nardil Luminol Orap Compazine Promazine Inderal Vivactil Metamucil * Vitamin B6 Seroquel Risperdal Zoloft Sulpitil Restoril Vitamin B1 Mellaril Navane Parnate Desyrel Generic Name Triazolam Trifluoperazine Trihexyphenidyl Trimipramine Valproic Acid Venlafaxine Zaleplon Zolpidem Zolpidem CR Ziprasidone Brand Name Halcion Stelazine Artane Surmontil Depakene Effexor, EffexorXR Sonata Ambien Ambien CR Geodon and prograf.
Treatment Group N * 101 97 90 Paroxetins LS Mean * 60.7 -9.8 -15.4 -19.7 -23.2 -24.3 -27.3 -22.6 SE ; 9.37 ; 1.13 ; 1.17 ; 1.34 ; 1.30 ; 1.39 ; 1.45 ; 1.47 ; N * 102 100 91 Placebo LS Mean * 62.6 -8.1 -14.0 -21.1 -23.7 -24.8 -26.5 -23.4 SE ; 8.96 ; 1.20 ; 1.24 ; 1.47 ; 1.36 ; 1.40 ; 1.47 ; 1.60 ; Treatment Comparison Difference 95% CI p-value - 0.84 0.80 - 4.54, 2.87 ; -3.09, 4.69 ; - - 0.655 0.684.
Use this visual guide to remind yourself that supporting a person who relies on psychotopic medications is not a linear, sequential process, but a wholistic set of simultaneous and interrelated activities and judgments and tacrolimus.
Hippocratic oath of physicians. The jury returned guilty verdicts on all ten counts of trafficking in drugs and all ten counts of illegal processing of drug documents. drug document The trial court merged the illegal processing of offenses into Defendant's ten drug trafficking, for example, paroxetine study.
Paxil cr paxil cr, which is generically prescribed paroxetine, is commonly used to treat obsessive-compulsive disorder, depression, anxiety disorders, post traumatic stress disorders, and premenstrual dysphoric disorders and pantoprazole.
The following information describes your Secure Horizons Prescription Advantages Plan pharmacy coverage. Please note that not all generic medications are included on the Secure Horizons Prescription Advantages Plan Covered Prescription Drug List. The Covered Prescription Drug List is updated periodically and is subject to change. If you choose to use a medication not included on the Secure Horizons Prescription Advantages Plan Covered Prescription Drug List, you will be responsible for the cost of the medication, for instance, paroxetinf mg.
Cymbalta; Effexor XR; Paxil CR; Pexeva; venlafaxine ST at least a 60 day consistent trial of 2 of the following: Lexapro, fluoxetine, paroxetine, citalopram, sertraline, bupropion SR in last 180 days. Wellbutrin XL ST at least a 60 day consistent trial of 2 of the following: bupropion SR or IR AND another preferred agent in last 180 days and pentoxifylline.
Date: 03 17 03ISR Number: 4077601-6Report Type: Expedited 15-DaCompany Report #EMADSS2003002091 Age: 75 YR Gender: Male I FU: I Outcome Dose Duration Death 0.5 MG, 3 IN Hospitalization 1 DAY S ; , Initial or Prolonged ORAL PT Bronchopneumonia Dementia Dry Mouth Muscle Spasms 75 MG, DAILY, ORAL Paroxetihe Paroxetine ; Ibuprofen Ibuprofen ; Aspirin Acetylsalicylic Acid ; Gaviscon Gaviscon 22-Aug-2005 Page: 641 10: 49 C C Report Source Foreign Health Professional Dothiepin Dosulepin ; Product Haldol Haloperidol ; Role PS Manufacturer Route ORAL.
For zomig, which cost $180 for 9 pills and trental.
There are few interfering substances in the final extract Figure 3 ; . The concentration of drug in an unknown sample may be determined by comparing the ratio of the peak area for the drug to that of the internal standard in the sample with the same ratio in several.
Chirac P. Translating the essential drugs concept into the context of the year 2000. Trans R Soc Trop Med Hyg 2003; 97: 10-2. Loff B. Patents and access to essential drugs. Trans R Soc Trop Med Hyg 2003; 97: 6-9. Ford N. Patents, access to medicines and the role of non-governmental organisations. J Generic Med 2004; 1: 137-145. Drug policy at the 55th World Health Assembly: ensuring accessibility of essential medicines. An interagency Briefing Paper from: Health Action International, Campaign for Access to Essential Medicines, Mdecins Sans Frontirs, Oxfam International, VSO, and Save the Children. Available from: : oxfam eng pdfs pp020511 WHA briefing . Accessed 10 February 2005. 12 Levy M, Reidenberg M. What has been the impact of the concept of essential drugs? Clin Pharm Ther 2003; 73: 275-278 and pheniramine and paroxetine, for example, parxoetine treatment.
According to the Surgeon General's Report 1999 ; the mental health system is not adequate to serve the needs of racial and minority groups. If a mental health assessment or treatment is not culturally competent it simply will not be fully effective. There is an important movement to improve the service delivery system through "linguistically and culturally competent services." Race, ethnicity and particular sets of beliefs, norms and values determine culture. The historical circumstances leading to a group's economic, social and political status are also a part of culture. Culture defines roles and behaviors and it governs ideas of what constitutes normal and abnormal behavior. It also shapes people's understanding of the cause of certain disturbances in behavior and emotion and how they describe those disturbances. Much of mental health assessment and treatment is based on the ability to understand and communicate through language. Linguistic competence refers to the ability to understand a person's use of their language. Culturally competent services incorporate respect for, and understanding of, ethnic and racial groups, as well as their histories, traditions, beliefs, and value systems CMHS, 1998 ; . Cultural competency doesn't just apply to assessment and psychotherapy. A new field of drug therapy seeks to understand the influence of race and culture on the effect of drugs used to treat mental illness. Research has demonstrated that there is wide variation among different races in how drugs metabolize and the exact effects of various drugs. There may also be interactions with the alternative healing methods used by various cultures.
CYP2D6 POLYMORPHISM Table 1. Inhibitors of CYP2D6. Ajmalicine Aprindine Chlorpromazine Clomipramine Flecainide Halofantrine Meclobemide Perazine Quinidine Resperidone Thioridazine Ajmaline Budipine Cimetidine Clozepine Fluoxamine Haloperidol Olanzapine Perphenazine Quinine Sertraline Ticlopidine Amitriptyline Bufuralol Cisthiothixene Desmethylimipramine Fluoxetine Levomepromazine Oxprenolol Propofenone Ranitidine Terbinafine Venlafaxine Amesergide Chloroquine Citalopram Diphenhydramine Fluphenazine Methadone Paroxetine Propranolol Reboxetine Terfenadine Yohimbine and progesterone.
Treatment Group Paroxetine Placebo Total Visit Statistic N 53 ; N 108 ; N MEAN MEDIAN STDDEV MINIMUM MAXIMUM MISSING N MEAN MEDIAN STDDEV MINIMUM MAXIMUM MISSING N MEAN MEDIAN STDDEV MINIMUM MAXIMUM MISSING N MEAN MEDIAN STDDEV MINIMUM MAXIMUM MISSING N MEAN MEDIAN 52 17.6 17.0 0 12.6 10.0 0 15.2 13.0 0 31 5.
Each drug is available in a 4 mg tablet, although other tablet strengths are also available for each.
Table 7: Drug-Herb interactions continued ; Bioreactivity Drug Herb citalopram, fluoxetine, St. SSRI's fluvoxamine, paroxetine, John's sertraline ; Wort.
Arlenewla posted - jan 14 2007 : 3: quote: originally posted by rob555 and i feel arlenes stern vibe that i better be careful with the other pills, because paroxrtine dosages.
The main objectives of FOTON are to study how foreign takeovers of firms in the Nordic countries affect local innovation capabilities and how this issue is approached by policy makers. FOTON is made up of three modules: The first module is a statistical exercise providing an overall picture of foreign industrial ownership in the Nordic countries. A quantitative analysis of the effects of foreign ownership on firms' innovation performance is presented in FOTON report No. 3: Corporate Innovation Activities - Does Ownership Matter? Report No. 1 has a short overview of available statistics. The second module consists of case studies of Nordic firms that have been taken over by foreign companies. To allow for inter-Nordic comparisons, takeovers within two specific industries have been selected: Pharmaceuticals and ICT. The main focus of the case studies is on how the takeovers have affected innovation capabilities, not only in the acquired firms but also through these firms' linkages to local actors in the surrounding innovation systems. Module 2 is presented in FOTON report No. 2: Impacts of Foreign Takeovers in the Nordic Countries - what do the company case studies tell us? Module 3 studies policy developments of importance for foreign direct investments in general. The policy analysis is included in FOTON report No. 1: Summary and Policy Recommendations. The reports can be downloaded for free from step.no foton. The FOTON team would like to thank the Nordic Innovation Centre for its support to this study. More information about NICe can be found at nordicinnovation . The following researchers have contributed to FOTON: NIFU STEP Studies in Innovation, Research and Education, Norway Per M. Koch Project Leader ; Siri Aanstad Assistant Project Leader ; Sverre Johan Herstad Amir Piric Svein Olav Ns Johan Hauknes Marianne Broch Nils Henrik Solum VTT Technical Research Centre of Finland, Finland Juha Oksanen Team Leader ; Nina Rilla Bernd Ebersberger RANNIS, Iceland Thorvald Finnbjrnsson Team Leader ; Elva Br Aalsteinsdttir Swedish Institute for Growth Policy Studies, ITPS, Sweden Anne-Christine Strandell Team Leader ; Hans Lf KTH ; Magnus Frostenson SSE ; Tommy Borglund SSE ; Katarina Arbin SSE ; Hans de Geer SSE ; DTU Technical University of Denmark, Department of Manufacturing Engineering and Management, IPL, Denmark Jrgen Lindgaard Pedersen Team Leader ; Martin Tlle and prandin.
Nadolol and placebo on syncope recurrence and patients' well-being. J Coll Cardiol 2002; 40: 499504. Theodorakis GN, Markianos M, Livanis EG et al. Central serotonergic responsiveness in neurocardiogenic syncope: a clomipramine test challenge. Circulation 1998; 98: 272430. Grubb BP. Pathophysiology and differential diagnosis of neurocardiogenic syncope. J Cardiol 1999; 84: 3Q9Q. Grubb BP, Samoil D, Kosinski D et al. The use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Coll Cardiol 1994; 24: 4904. Di Girolamo E, Di Iorio C, Sabatini P et al. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Coll Cardiol 1999; 33: 122730. Theodorakis GN, Markianos M, Zarvalis E et al. Provocation of neurocardiogenic syncope by clomipramine administration during the headup tilt test in vasovagal syndrome. J Coll Cardiol 2000; 36: 1748. Theodorakis GN, Livanis E, Leftheriotis D, Flevari P, Markianos M, Kremastinos D Th. Head-up tilt test with clomipramine challenge in vasovagal syndrome--a new tilt testing protocol. Eur Heart J 2003; 24: 65863. Connolly SJ, Sheldon R, Roberts RS, Gent M, on behalf of the vasovagal pacemaker study investigators. The North American Vasovagal Study VPS ; . A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Coll Cardiol 1999; 33: 1620. Carey BJ, Manktelow BN, Panerai RB, Potter JF. Cerebral autoregulatory responses to head-up tilt in normal subjects and patients with recurrent vasovagal syncope. Circulation 2001; 104: 898902. Sutton R, Brignole M, Menozzi C et al., for the VASIS Investigators. Dualchamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: a multicenter randomized study. Circulation 2000; 102: 2949. Dabire H. Central 5-hydroxytryptamine 5-HT ; receptors in blood pressure regulation. Therapie 1991; 46: 4219. Kubo T, Taguchi K, Ozaki S et al. 8-OH-DPAT-indused hypotensive action and sympathoexcitatory neurons in the rostal ventrolateral medulla of the rat. Brain Res Bull 1995; 36: 40511. Angelopoulos E, Markianos M, Daskalopoulou E et al. Neuroendocrine responsitivity to clomipramine challenge test in neuroleptic naive psychotic patients before and after treatment with haloperidol. Eur Psychiat 1997; 12: 3626. Hollander E, Cohen LJ, DeCaria C et al. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD. Biol Psychiat 1993; 34: 40713. Grubb BP, Kosinski DJ. Serotonin and syncope: an emerging connection? Eur J Cardiac Pacing Electrophysiol 1995; 5: 30614. Rickels K, Schweizer E. Clinical overview of serotonin reuptake inhibitors. J Clin Psychiat 1990; 51: 912. Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope. Circulation 2001; 104: 527. Kouakam C, Vaksmann G, Pachy E, Lacroix D, Rey C, Kacet S. Long-term follow-up of children and adolescents with syncope. Eur Heart J 2001; 22: 161825. Reybrouck T, Heidbuchel H, Van de Werf F, Ector H. Long term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 2002; 25: 14416. Linzer M, Pontinen M, Gold DT et al. Impairment of physical and psychological function in recurrent syncope. J Clin Epidemiol 1991; 44: 103744. Moya A, Permanyer-Miralda G, Sagrista-Sauleda J et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. J Coll Cardiol 1995; 25: 659. Sheldon R, Koshman ML, Wilson W, Kieser T, Rose S. Effect of dualchamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. J Cardiol 1998; 81: 15862. Moya A, Brignole M, Menozzi C et al. Mechanism of syncope in patients with isolated syncope and patients with tilt-positive syncope. Circulation 2001; 104: 12617.
Paroxetine and withdrawal symptoms
Aortic counterpulsation balloon, collapsed lung atelectasis, propecia 5mg, diverticulosis nursing care plan and azoospermia with normal fsh levels. Adnexa ultrasound, losartan msds, thalomid dosing and arthrotec dangers or haloperidol msds.
Discount Paroxetine
Paroxetine hcl drug antidepressants, paroxetine treatment of generalized anxiety disorder, paroxetine and withdrawal symptoms, discount paroxetine and paroxetine patent. Paroxetine for premature ejaculation, adverse effects of paroxetine, generic paroxetine manufacturers and paroxetine generics or paxil paroxetine.
|
